Migraines & headaches Board decisions

Service connection for bilateral hearing loss is granted. All other conditions are denied or remanded.

The Board denied the veteran's claims for earlier effective dates for PTSD and migraines, and a higher combined disability rating, based on clear and unmistakable error.

The Board denied the veteran's claims for increased ratings for PTSD and headaches, finding that the evidence did not support a higher rating.

The Board denied the veteran's request for special monthly compensation (SMC) based on the need for regular aid and attendance for TBI residuals. The evidence did not show a need for a higher level of care by a licensed professional.

The veteran's disability rating for IVDS of the cervical spine was restored to 20 percent. Service connection was granted for left and right upper extremity radiculopathy. Other issues were remanded.

The Board granted service connection for the veteran's headaches, finding that the evidence was at least evenly balanced regarding a causal relationship to active-duty service.

Service connection for obstructive sleep apnea is granted. The claim for migraine headaches is remanded for further evaluation.

The veteran's request for a higher rating for an acquired psychiatric condition was denied. Service connection for tension headaches was granted, but service connection for chronic fatigue, chronic fatigue syndrome, joint pain, muscle pain, and bilateral hearing loss was denied.

The veteran's claims for a higher rating of migraine headaches and PTSD with major depressive disorder and major neurocognitive disorder due to TBI residuals, as well as special monthly compensation on a statutory housebound basis, were granted.

The Board remanded the claim for service connection of ocular migraines because the medical opinion was inadequate. The Veteran's claim will be reconsidered with new evidence.

The Board granted service connection for bilateral restless leg syndrome, migraines, and vertigo as secondary to the Veteran's service-connected persistent depressive disorder.

The veteran's claim for service connection of major depressive disorder (MDD) with anxious distress, secondary to tinnitus, was granted. The claim for headaches is being sent back for further review.

The Board denied service connection for several conditions, including left ear hearing loss, right knee disability, hypertension, headaches, bilateral plantar fasciitis, and sleep disorder. It also denied a compensable rating for pseudofolliculitis barbae (PFB), right ear hearing loss, and a higher rating for tinnitus. The claim for service connection for a bilateral eye disability was remanded.

The Board remanded the veteran's claims for service connection for headaches and back disability due to pre-decisional errors. The veteran will receive new medical opinions.

The Board remanded the Veteran's claims for service connection for sleep apnea, migraines, and an effective date prior to January 17, 2022, for a 60 percent rating for asthma and COPD. The Board found that additional examinations and opinions are needed.

The veteran's claims for service connection for migraines and asthma were granted. The migraines are directly related to military service, and the asthma is presumptively associated with exposure to fine particulate matter in Southwest Asia.

The veteran's claim for a higher rating for tinnitus was denied. The claims for service connection for headaches, hypertension, and TBI were remanded.

The veteran's effective date for a 50% rating for service-connected migraine headaches is granted as of March 27, 2014.

The Board denied the veteran's claim for an earlier effective date for service connection for adjustment disorder with depressed mood. The decision was based on the lack of new and material evidence within one year of previous denials.

The veteran's claim for service connection for unspecified depressive disorder secondary to TBI was granted with an effective date of July 10, 2020. The veteran was assigned a 70% rating for this condition and a 50% rating for migraines. A 30% rating for right foot strain beginning April 22, 2022, and TDIU were also granted.